Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher cardiometabolic risks.

Allium ascalonicum L. extract may help improve insulin resistance.

Women with PCOS have altered brain structure and reduced cognitive performance.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

AR gene variations don't affect aging markers in men.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

SGLT2 inhibitors may help manage PCOS symptoms effectively.